- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
GlaxoSmithKline (GSK) appointed Brian McNamara CEO of its consumer healthcare division on Wednesday.
This pharmaceutical giant has struggled in recent years but is wisely repositioning itself as the world's largest manufacturer of vaccines.
Here is a look at two big pharma stalwarts to determine the better stock to buy for growth and income.